GENOMIC TESTING

July 18th 2024

As the clinical utility of ctDNA continues to be assessed, it is becoming a valuable tool for various cancer types, including gastrointestinal cancers, blood cancers, and other solid tumors.

April 19th 2024

Druggable gene aberrations and predictive biomarkers has allowed for the use of next-generation sequencing technologies to grow.

April 11th 2024

In an interview with Targeted Oncology, Sara Kerr, MD discussed the evolution of genomic testing for patients with cancer and highlighted the program used at Allina Health.

March 28th 2024

In an interview with Targeted Oncology, David L. Bartlett, MD, discussed the utilization and growing importance of genomic testing in cancer care.